Literature DB >> 32217857

Patient-Reported Bowel Function in Patients With Rectal Cancer Managed by a Watch-and-Wait Strategy After Neoadjuvant Therapy: A Case-Control Study.

Felipe F Quezada-Diaz1, J Joshua Smith1, Rosa M Jimenez-Rodriguez1, Isaac Wasserman1, Emmanouil P Pappou1, Sujata Patil2, Iris H Wei1, Garrett M Nash1, Jose G Guillem1, Martin R Weiser1, Philip B Paty1, Julio Garcia-Aguilar1.   

Abstract

BACKGROUND: A watch-and-wait strategy is a nonoperative alternative to sphincter-preserving surgery for patients with locally advanced rectal cancer who achieve a clinical complete response after neoadjuvant therapy. There are limited data about bowel function for patients undergoing this organ-preservation approach.
OBJECTIVE: The purpose of this study was to compare bowel function in patients with rectal cancer managed with a watch-and-wait approach with bowel function in patients who underwent sphincter-preserving surgery (total mesorectal excision).
DESIGN: This was a retrospective case-control study using patient-reported outcomes. SETTINGS: The study was conducted at a comprehensive cancer center. PATIENTS: Twenty-one patients underwent a watch-and-wait approach and were matched 1:1 with 21 patients from a pool of 190 patients who underwent sphincter-preserving surgery, based on age, sex, and tumor distance from the anal verge. MAIN OUTCOME MEASURES: Bowel function was measured using the Memorial Sloan Kettering Cancer Center Bowel Function Instrument.
RESULTS: Patients in the watch-and-wait arm had better bowel function on the overall scale (median total score, 76 vs 55; p < 0.001) and on all of the subscales, with the greatest difference on the urgency/soilage subscale (median score, 20 vs 12; p < 0.001). LIMITATIONS: The study was limited by its retrospective design, small sample size, and temporal variability between surgery and time of questionnaire completion.
CONCLUSIONS: A watch-and-wait strategy correlated with overall better bowel function when compared with sphincter-preserving surgery using a comprehensive validated bowel dysfunction tool. See Video Abstract at http://links.lww.com/DCR/B218. FUNCIÓN EVACUATORIA INFORMADA POR PACIENTES EN CÁNCER RECTAL MANEJADO CON UNA ESTRATEGIA DE OBSERVAR Y ESPERAR DESPUÉS DE LA TERAPIA NEOADYUVANTE: UN ESTUDIO DE CASOS Y CONTROLES: Observar y esperar es una alternativa no operativa a la cirugía de preservación del esfínter para pacientes con cáncer rectal localmente avanzado que logran una respuesta clínica completa después de la terapia neoadyuvante. Hay datos limitados sobre la función evacuatoria en pacientes sometidos a este abordaje para preservación de órganos.Evaluar la función evacuatoria en pacientes con cáncer rectal manejados con observar y esperar comparado a pacientes sometidos a cirugía de preservación de esfínteres (escisión mesorrectal total).Estudio retrospectivo de casos y controles utilizando resultados reportados por pacientes.Centro especializado oncológico.21 pacientes se sometieron a observar y esperar y se compararon con 21 pacientes de un grupo de 190 pacientes que se sometieron a cirugía de preservación de esfínteres controlando por edad, sexo y la distancia del tumor al borde anal.Función evacuatoria utilizando un instrumento de valoración del Centro de Cáncer Memorial Sloan Kettering.Los pacientes de observar y esperar demostraron mejor función evacuatoria en la escala general (puntuación total media, 76 versus 55; p <0,001) y en todas las subescalas, con la mayor diferencia en la subescala de urgencia / ensuciamiento fecal (puntuación media, 20 versus 12; p <0,001).Diseño retrospectivo, numero de muestra pequeño y variabilidad temporal entre la cirugía y el tiempo de finalización del cuestionario.Observar y esperar se correlacionó con mejor función evacuatoria en general en comparación con la cirugía de preservación del esfínter utilizando una herramienta integral validada para la disfunción evacuatoria. Consulte Video Resumen en http://links.lww.com/DCR/B218. (Traducción-Dr. Adrián Ortega).

Entities:  

Mesh:

Year:  2020        PMID: 32217857      PMCID: PMC7274891          DOI: 10.1097/DCR.0000000000001646

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.412


  29 in total

1.  The construction and testing of the EORTC colorectal cancer-specific quality of life questionnaire module (QLQ-CR38). European Organization for Research and Treatment of Cancer Study Group on Quality of Life.

Authors:  M A Sprangers; A te Velde; N K Aaronson
Journal:  Eur J Cancer       Date:  1999-02       Impact factor: 9.162

2.  Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer.

Authors:  Monique Maas; Regina G H Beets-Tan; Doenja M J Lambregts; Guido Lammering; Patty J Nelemans; Sanne M E Engelen; Ronald M van Dam; Rob L H Jansen; Meindert Sosef; Jeroen W A Leijtens; Karel W E Hulsewé; Jeroen Buijsen; Geerard L Beets
Journal:  J Clin Oncol       Date:  2011-11-07       Impact factor: 44.544

3.  Manometric and clinical evaluation of patients after low anterior resection for rectal cancer.

Authors:  C Efthimiadis; G Basdanis; A Zatagias; I Tzeveleki; C Kosmidis; E Karamanlis; N Harlaftis
Journal:  Tech Coloproctol       Date:  2004-11       Impact factor: 3.781

4.  Function of the distal rectum after low anterior resection for carcinoma.

Authors:  N D Karanjia; D J Schache; R J Heald
Journal:  Br J Surg       Date:  1992-02       Impact factor: 6.939

5.  Prospective comparison of faecal incontinence grading systems.

Authors:  C J Vaizey; E Carapeti; J A Cahill; M A Kamm
Journal:  Gut       Date:  1999-01       Impact factor: 23.059

6.  Quality of Life in Patients With Rectal Cancer After Chemoradiation: Watch-and-Wait Policy Versus Standard Resection-Are We Comparing Apples to Oranges?

Authors:  Bruna Borba Vailati; Angelita Habr-Gama; Adrian E Mattacheo; Guilherme Pagin São Julião; Rodrigo Oliva Perez
Journal:  Dis Colon Rectum       Date:  2018-03       Impact factor: 4.585

7.  The development of a validated instrument to evaluate bowel function after sphincter-preserving surgery for rectal cancer.

Authors:  Larissa K Temple; Jennifer Bacik; Salvatore G Savatta; Lester Gottesman; Philip B Paty; Martin R Weiser; José G Guillem; Bruce D Minsky; Michelle Kalman; Howard T Thaler; Deborah Schrag; W Douglas Wong
Journal:  Dis Colon Rectum       Date:  2005-07       Impact factor: 4.585

8.  Patient Perceptions and Quality of Life After Colon and Rectal Surgery: What Do Patients Really Want?

Authors:  Sean M Wrenn; Antonio Cepeda-Benito; Diego I Ramos-Valadez; Peter A Cataldo
Journal:  Dis Colon Rectum       Date:  2018-08       Impact factor: 4.585

9.  Development and external validation of a nomogram and online tool to predict bowel dysfunction following restorative rectal cancer resection: the POLARS score.

Authors:  Nick J Battersby; George Bouliotis; Katrine J Emmertsen; Therese Juul; Rob Glynne-Jones; Graham Branagan; Peter Christensen; Søren Laurberg; Brendan J Moran
Journal:  Gut       Date:  2017-01-23       Impact factor: 23.059

10.  Local recurrence after complete clinical response and watch and wait in rectal cancer after neoadjuvant chemoradiation: impact of salvage therapy on local disease control.

Authors:  Angelita Habr-Gama; Joaquim Gama-Rodrigues; Guilherme P São Julião; Igor Proscurshim; Charles Sabbagh; Patricio B Lynn; Rodrigo O Perez
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-02-01       Impact factor: 7.038

View more
  9 in total

1.  ASO Author Reflections: Identifying Rectal Cancer Patients Suitable for Watch-and-Wait.

Authors:  Jin K Kim; Julio Garcia-Aguilar
Journal:  Ann Surg Oncol       Date:  2021-10-06       Impact factor: 5.344

Review 2.  Nonoperative Management for Rectal Cancer.

Authors:  Felipe F Quezada-Diaz; J Joshua Smith
Journal:  Hematol Oncol Clin North Am       Date:  2022-05-11       Impact factor: 2.861

Review 3.  Non-Operative Management of Patients with Rectal Cancer: Lessons Learnt from the OPRA Trial.

Authors:  Paolo Goffredo; Felipe F Quezada-Diaz; Julio Garcia-Aguilar; J Joshua Smith
Journal:  Cancers (Basel)       Date:  2022-06-30       Impact factor: 6.575

Review 4.  Neoadjuvant Therapy for Rectal Cancer.

Authors:  Felipe F Quezada-Diaz; J Joshua Smith
Journal:  Surg Oncol Clin N Am       Date:  2022-03-09       Impact factor: 2.402

5.  Adoption of Organ Preservation and Surgeon Variability for Patients with Rectal Cancer Does Not Correlate with Worse Survival.

Authors:  Jin K Kim; Hannah Thompson; Rosa M Jimenez-Rodriguez; Fan Wu; Francisco Sanchez-Vega; Garrett M Nash; Jose G Guillem; Philip B Paty; Iris H Wei; Emmanouil P Pappou; Maria Widmar; Martin R Weiser; J Joshua Smith; Julio Garcia-Aguilar
Journal:  Ann Surg Oncol       Date:  2021-10-03       Impact factor: 5.344

Review 6.  Watch-and-wait Management for Rectal Cancer After Clinical Complete Response to Neoadjuvant Therapy.

Authors:  Jonathan B Yuval; Julio Garcia-Aguilar
Journal:  Adv Surg       Date:  2021-07-06

7.  Robotic surgery contributes to the preservation of bowel and urinary function after total mesorectal excision: comparisons with transanal and conventional laparoscopic surgery.

Authors:  Takuya Miura; Yoshiyuki Sakamoto; Hajime Morohashi; Akiko Suto; Shunsuke Kubota; Aika Ichisawa; Daisuke Kuwata; Takahiro Yamada; Hiroaki Tamba; Shuntaro Matsumoto; Kenichi Hakamada
Journal:  BMC Surg       Date:  2022-04-21       Impact factor: 2.030

8.  Comparative analysis of the Memorial Sloan Kettering Bowel Function Instrument and the Low Anterior Resection Syndrome Questionnaire for assessment of bowel dysfunction in rectal cancer patients after low anterior resection.

Authors:  Felipe F Quezada-Diaz; Hossam Elfeki; Katrine J Emmertsen; Emmanouil P Pappou; Rosa Jimenez-Rodriguez; Sujata Patil; Søren Laurberg; Julio Garcia-Aguilar
Journal:  Colorectal Dis       Date:  2021-02-10       Impact factor: 3.917

9.  Effects of Preoperative Radiotherapy on Long-Term Bowel Function in Patients With Rectal Cancer Treated With Anterior Resection: A Systematic Review and Meta-analysis.

Authors:  Zongyu Liang; Zhaojun Zhang; Deqing Wu; Chengzhi Huang; Xin Chen; Weixian Hu; Junjiang Wang; Xingyu Feng; Xueqing Yao
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.